Skip to main content
Clinical Trials/KCT0006805
KCT0006805
Completed
未知

Adequate infusion rate of remimazolam for induction of general anesthesia in adult patients

Samsung Medical Center0 sites44 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Samsung Medical Center
Enrollment
44
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 28, 2022
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) ASA class I \- III
  • 2\) Age between 19 to 65
  • 2\) Patient who has elective surgery under general anesthesia

Exclusion Criteria

  • 1\) Children (under 18 years old)
  • 2\) BMI\>30kg/m2 or \<18\.5kg/m2
  • 3\) People with severe liver disease
  • 4\) Neuromuscular disease or mental illness
  • 5\) metabolic disease
  • 6\) drug or alcohol addiction
  • 7\) Emergency surgery
  • 8\) Pregnant women, lactating women
  • 9\) Those who are contraindicated in benzodiazepine drugs and sevoflurane (e.g., patients who are allergic to drugs or have a history of hypersensitivity reactions)
  • 10\) Patients with acute narrow\-angle glaucoma

Outcomes

Primary Outcomes

Not specified

Similar Trials